(2-甲基-2H-吲唑-5-基)硼酸, (2-Methyl-2H-indazol-5-yl)boronic acid

2-溴-5-氟-1,3-噻唑, 2-Bromo-5-fluoro-1,3-thiazole

4-(2-氨基噻唑-4-基)苯酚, 4-(2-Aminothiazol-4-yl)phenol

1-(11bR)-二萘[2,1-d:1',2'-f][1,3,2]二氧杂膦-4-基-1,2,3,4-四氢喹啉, 1-(11bR)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl

N-[(8α,9S)-6'-甲氧基奎宁-9-基]-N'-[(2S)-2-吡咯烷基甲基]硫脲, N-[(8α,9S)-6'-Methoxycinchonan-9-yl]-N'-[(2S)-2-pyrrolidinyl

鲁拉西酮杂质3, Lurasidone Impurity 3

莫西沙星杂质D, Moxifloxacin Impurity D

2-溴噻唑-4-甲酰胺, 2-Bromothiazole-4-carboxamide

8-溴咪唑并[1,2-a]吡啶-6-羧酸甲酯, Methyl 8-bromoimidazo[1,2-a]pyridine-6-carboxylate

4-((4-溴-2-甲基苯基)磺酰基)吗啉, 4-((4-Bromo-2-methylphenyl)sulfonyl)morpholine